Simulation of clinical trials.
By N. Holford, H. Kimko, J. Monteleone, C. Peck. 2000
285 citations recorded by the source corpus.
Subfields: Economics and Econometrics, Immunology, Statistics and Probability
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
- Doina Precup
- Volodymyr Kuleshov
- Somesh Jha
- Thomas Ristenpart
- Eric Lantz
- Simon M. Lin
- David Page
- Matt Fredrikson
In Statistics and Probability
- Doina Precup
- Volodymyr Kuleshov
- Somesh Jha
- Thomas Ristenpart
- Eric Lantz
- Simon M. Lin
- David Page
- Matt Fredrikson
Citations in the corpus
- Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing (2014, positive): “The practice of simulating clinical trials is wellknown in the medical research literature [4, 14, 18, 19], where it is used to estimate the impact of various decisions before initiating a costly real-world trial involving human subjects.”
- Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of Gliclazide (2006, unknown): “simulation of clinical trials [4-6].”
- Simulation and prediction of in vivo drug metabolism in human populations from in vitro data (2007, background): “during a teaching course for doctors and scientists who were interested in learning about practical difficulties and sources of error in clinical trial design and performanc”
- Algorithms for multi-armed bandit problems (2014, background): “A thorough overview of the literature on simulating clinical trials can be found in Holford et al. (2000).”